Clinical Trials Directory

Trials / Completed

CompletedNCT06020911

Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars

Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
4 Years – 7 Years
Healthy volunteers
Not accepted

Summary

this study is aimed to conduct tomographic evaluation of reparative dentin bridges formed after indirect pulp capping with Biodentine and Theracal light cured. The null hypothesis of the study is that there will be no difference in the quantity and quality of reparative dentin formation between the tested materials used for the indirect pulp capping

Detailed description

Many materials have been used in indirect pulp capping for primary dentition. An ideal pulp capping material is to be successful when it is biocompatible, radiopaque, maintain good seal, protect the pulp against bacterial invasion in both long and short run, release sustained amounts of calcium ions, act as reservoir for calcium hydroxide and stimulate reparative dentin formation through inducing the pulp cells to form odontoblasts. Theracal light cured is a light-cured resin modified calcium silicate (RMCS) used as an indirect pulp capping material. It releases more calcium ions than Mineral trioxide aggregate or dycal inducing reparative dentin and dentin bridge formation.Theracal light cured showed better sealing ability and less microleakage than Mineral trioxide aggregate and Biodentine

Conditions

Interventions

TypeNameDescription
DRUGBiodentine17 primary second molars of 17 children will be capped with Biodentine
DRUGTheracal light cured17 primary second molars of 17 children will be capped with Theracal light cured

Timeline

Start date
2023-01-30
Primary completion
2023-10-01
Completion
2023-10-01
First posted
2023-09-01
Last updated
2024-05-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06020911. Inclusion in this directory is not an endorsement.